Radiesse Injectable Approved for Décolleté Area

Merz Aesthetics has announced that Radiesse has been approved in the European Union to treat the décolleté area.

Radiesse is a dermal filler that uses calcium hydroxylapatite microspheres to stimulate collagen production and promote skin rejuvenation. It is primarily utilised for smoothing moderate to severe facial wrinkles and folds.

Approval to treat the décolleté area comes from a large, multicentre clinical trial which provided substantial evidence of Radiesse’s effectiveness, demonstrating a significant improvement in the appearance of décolleté wrinkles.

Results from the clinical trial found that:

• Up to 73.5% of patients experienced improved décolleté wrinkles 16 weeks after their last treatment
• 76.1% of patients demonstrated an enhancement in skin quality over the same period
• Physicians reported a high level of satisfaction among 77% of patients 16 weeks after their last treatment

“Our data showcases Radiesse’s effectiveness in reducing décolleté wrinkles.” said Gonzalo Mibelli, EMEA President, Merz Aesthetics. “This approval also reflects a broader shift toward minimally invasive procedures driven by patients’ evolving preferences for enhancing their body’s anti-aging processes for aesthetic improvements.”

He continued, “The approval of the Radiesse décolleté indication is an exciting time for Merz Aesthetics. We can see that while there is a steady rise in the number of patients seeking to smooth wrinkles in the décolleté area, patients equally want more healthy-looking results and improved skin quality. This is something that Merz Aesthetics can support them with.”